CVS to pay $315 million to settle federal claims over illegal controlled‑substance prescriptions
The U.S. Department of Justice announced that CVS Pharmacy Inc. will pay $315 million to resolve accusations that it filled opioid and other controlled‑substance prescriptions in violation of the Controlled Substances Act and the False Claims Act from October 2013 through December 2025. The settlement also requires CVS to enter into an agreement with the Drug Enforcement Administration to install new monitoring and reporting safeguards. CVS denies the allegations and does not admit liability.
Why it matters
The payment creates a direct cash outflow for CVS and may affect its earnings for the quarter in which the settlement is recorded, as noted by the DOJ press release. The required DEA safeguards could increase operating costs and change pharmacy dispensing practices.
Key facts
- 1CVS will pay $315 million to settle the federal claims. presidentialprayerteam.org
- 2The alleged illegal prescriptions span from October 2013 to December 2025. presidentialprayerteam.org
- 3The DOJ filed the complaint in December 2024 in federal court in Rhode Island. health.yahoo.com
- 4The settlement includes a DEA agreement that obliges CVS to create a hotline, proactively monitor dispensing patterns, and evaluate prescribers suspected of illegal prescribing. health.yahoo.com
- 5CVS does not admit wrongdoing and the settlement contains no finding of liability. health.yahoo.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.